Role of IGF-1 and insulin receptors beta-cell survival
Role of IGF-1 and insulin receptors beta-cell survival
批准号:
8036418
负责人:
ROHIT N. KULKARNI
金额:
$8.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-15 至 2011-02-28
关键词:
AbbreviationsAddressApoptosisApoptoticBeta CellBinding ProteinsBiologyBoxingCell LineCell ProliferationCell SurvivalCellsCollaborationsComplementDataData ReportingDiseaseEmployee StrikesEndoplasmic ReticulumFailureFamilyFundingGene ExpressionGeneticGenetically Engineered MouseGoalsGrantGrowthGrowth FactorHomeodomain ProteinsHyperplasiaIGF-1 Signaling PathwayIn VitroInsulinInsulin ReceptorInsulin ResistanceInsulin Signaling PathwayInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorKnock-outKnockout MiceLaboratoriesLinkManuscriptsMediatingModelingMusNatural regenerationNon-Insulin-Dependent Diabetes MellitusPancreasPaperPathway interactionsPhosphotransferasesProcessProhormone ConvertaseProinsulinProteinsProteomeProto-OncogenesProtocols documentationPublishingReagentRegulationRoleSerineSignal PathwaySignal TransductionSiteSomatomedinsTestingTherapeuticThreonineTimeTuberous sclerosis protein complexWorkabstractingbasebiological adaptation to stresscarboxypeptidase Hcell growthcyclin D2endoplasmic reticulum stressfollow-uphuman IRS2 proteinin vivoin vivo Modelinsightisletmouse modelmutantnovelprohormonereceptorresearch studyresponsetype I and type II diabetes
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
A paucity of functional ¿-cells is a central feature of type 1 and type 2 diabetes and an
urgent question in islet biology relates to plasticity of ¿-cell mass in the long-term goal of
developing strategies to treat both forms of the disease. This application is focused on the
role of growth factors, especially insulin and IGF-I receptors and proteins in their signalling
pathway, in regulation of ¿-cell proliferation, apoptosis and secretory function. We use
unique genetic mouse models lacking one or more proteins in the insulin/IGF-I signalling
pathway in ¿-cells and complement with studies in ¿ cell lines and primary islets derived
from the knockouts for in vitro and ex vivo experiments. Based on Preliminry Data we seek
to continue our studies with the following Specific Aims: Aim 1: Determine the role of
insulin/IGF-I signaling in proinsulin processing and test the hypothesis that an intact
insulin/IRS-2 pathway is essential for appropriate proinsulin processing. Aim 2: Define the
alterations in endoplasmic reticulum (ER) stress in ¿ cells lacking proteins in the insulin
signaling pathway and test the hypothesis that the insulin/IRS-2 pathway is essential to limit
ER stress in ¿ cells: Our preliminary data indicates a direct role for the insulin receptor and
IRS-2, but not IRS-1, in ER stress responses in ¿ cells. We plan to dissect the mechanisms
and pathways that underlie enhanced ER stress in the context of insulin/IRS-2 signaling
with a focus on IRE-1a and contrast the findings with the pathways mediated by IRS-1. Aim
3: Dissect the mechanisms that link the insulin/IGF-I signaling with proteins involved in the
¿-cell growth response to insulin resistance: Our preliminary data using in vivo approaches
builds on previous work and indicates critical roles for cyclin D2 and Px-1 in the
compensatory islet growth response to insulin resistance. We will focus on these two
proteins and explore their link with FoxO1 to dissect the mechanisms that underlie the
proliferation responses especially in the context of differences between insulin and IGF-1
signaling. Aim 4: Define the islet and ¿-cell proteome in mouse models of islet hyperplasia
with a focus on identifying novel proteins involved in ¿-cell proliferation and anti-apoptosis.
Together we believe thee studies will provide novel insights into the role of growth factors in
the regulation of ¿-cell proliferation and apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes
-
批准号:10278303
-
项目类别:
-
资助金额:$55.68万
-
财政年份:2021
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes
-
批准号:10477373
-
项目类别:
-
资助金额:$51.69万
-
财政年份:2021
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Enhanced pancreatic islet cell engraftment by treatment with serpin B1
-
批准号:10383270
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2021
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Interplay between SerpinB1 and TLR2/TLR4 in beta cell regeneration
-
批准号:10094305
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2020
-
负责人:ROHIT N. KULKARNI
-
依托单位:
One-compound, one-islet: A high-throughput platform for small-molecule discovery
-
批准号:10450745
-
项目类别:
-
资助金额:$74.66万
-
财政年份:2019
-
负责人:ROHIT N. KULKARNI
-
依托单位:
One-compound, one-islet: A high-throughput platform for small-molecule discovery
-
批准号:10356005
-
项目类别:
-
资助金额:$76.11万
-
财政年份:2019
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
-
批准号:10301008
-
项目类别:
-
资助金额:$50.3万
-
财政年份:2018
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
-
批准号:10378332
-
项目类别:
-
资助金额:$20.53万
-
财政年份:2018
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Regulation of Autoimmune Type 1 Diabetes by Serpins B1 and A1 (Alpha 1-Antitrypsin)
-
批准号:9556000
-
项目类别:
-
资助金额:$21.84万
-
财政年份:2018
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
-
批准号:10062405
-
项目类别:
-
资助金额:$50.69万
-
财政年份:2018
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction
-
批准号:10853540
-
项目类别:
-
资助金额:$6.22万
-
财政年份:2015
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction
-
批准号:10058354
-
项目类别:
-
资助金额:$69.76万
-
财政年份:2015
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction
-
批准号:10200026
-
项目类别:
-
资助金额:$66.28万
-
财政年份:2015
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction
-
批准号:10583551
-
项目类别:
-
资助金额:$65.5万
-
财政年份:2015
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction
-
批准号:10352454
-
项目类别:
-
资助金额:$65.9万
-
财政年份:2015
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of 12-lipoxygenase and 12-HETE signaling in beta-cell dysfunction
-
批准号:10338534
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2015
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of SerpinB1 in beta cell growth
-
批准号:8913169
-
项目类别:
-
资助金额:$50.06万
-
财政年份:2014
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Regulatory Networks and Biomarkers of Beta-cell Dysfunction and Apoptosis
-
批准号:9166075
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2014
-
负责人:ROHIT N. KULKARNI
-
依托单位:
Role of SerpinB1 in beta cell growth
-
批准号:8774789
-
项目类别:
-
资助金额:$51.92万
-
财政年份:2014
-
负责人:ROHIT N. KULKARNI
-
依托单位:
EXAMINATION OF LIRKO ISLETS AND SERUM USING QUANTITATIVE PROTEOMIC APPROACHES
-
批准号:8365464
-
项目类别:
-
资助金额:$2.87万
-
财政年份:2011
-
负责人:ROHIT N. KULKARNI
-
依托单位:
海外基金